Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29364480)

  • 1. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
    Li HS; Lv RQ; Liu L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between BMP4 expression and pathology, CT characteristics and prognosis of non-small cell lung cancer.
    Ju FJ; Meng FQ; Hu HL; Liu J
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5787-5794. PubMed ID: 31298330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer.
    Liu J; Lin Y; Yang H; Deng Q; Chen G; He J
    Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer].
    Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
    Hu FY; Wang LP; Hou LL; Yin G; Wang HC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features.
    Sun Y; Su B; Zhang P; Xie H; Zheng H; Xu Y; Du Q; Zeng H; Zhou X; Chen C; Gao W
    Oncol Rep; 2013 Feb; 29(2):704-12. PubMed ID: 23228962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
    Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
    Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.
    He J; Zhou F; Shao K; Hang J; Wang H; Rayburn E; Xiao ZX; Lee SW; Xue Q; Feng XL; Shi SS; Zhang CY; Zhang S
    Lung Cancer; 2007 Apr; 56(1):51-8. PubMed ID: 17275947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of surviving gene and its relationship with expression of P53, c-myc, k-ras proteins in non-small-cell lung cancer].
    Wang X; Chen S; Zhang Z
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):371-4. PubMed ID: 11802993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis.
    Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J
    Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
    Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations of Twist Expression with Pathological and Computed Tomography (CT) Characteristics and Prognosis of Non-Small Cell Lung Cancer (NSCLC).
    Duan F; Hao D; Xu W; Zhong X; Luo T
    Med Sci Monit; 2019 Feb; 25():977-983. PubMed ID: 30714578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
    Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
    Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Message RNA expression of LUNX, CK19 and CEA genes in NSCLC with micrometastasis in lymph nodes].
    Wang WB; Cui YG; Yao SY
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):121-4. PubMed ID: 18646695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the correlation between CT features and expression of p53 protein and PCNA in peripheral lung cancer].
    Chen J; Zhang H; Huang X
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):361-4. PubMed ID: 10921032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
    Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
    Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.